FMC Corp vs Progressive Corp — how do they compare? FMC Corp trades at $10.12 (market cap $1.30B), while Progressive Corp trades at $210 (market cap $123.45B). The key difference: Progressive Corp is far larger — about 95× FMC Corp's market cap, and Progressive Corp pays the higher dividend (6.55%). Which is the better fit depends on your goals.
| FMC | PGR | |
|---|---|---|
Market Cap | $1.30B | $123.45B |
Sector | Basic Materials | Financials |
52-Week High | $40.69 | $252.68 |
52-Week Low | $10.01 | $190.40 |
Enterprise Value | $5.11B | $131.66B |
Dividend Yield | 3.07% | 6.55% |
Signals from Pluang's Aura AI — not financial advice
FMC stock trades at $10.46, down 1.23% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $2.24 billion in 2025, with negative profitability margins, though recent quarters show mixed earnings beats. Analyst consensus is divided, with a $11.60 price target, while recent news highlights revenue challenges and strategic moves like a $400 million investment from Tessenderlo Group to reduce debt.
The outlook remains cautious due to persistent losses and weak revenue trends, but debt reduction efforts and cost controls offer some stability. Key risks include competitive pressures and macroeconomic headwinds, while the current valuation metrics like P/S of 0.4 may attract value investors if operational improvements materialize.
Progressive (PGR) trades at $213.95, down 0.64% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamental performance with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Recent Q2 2026 earnings beat expectations at $4.85 per share, though the combined ratio widened to 87.1%, indicating potential growth trade-offs. Analyst consensus price target stands at $231.20 with 37% buy ratings.
PGR presents a compelling investment case with reasonable valuation (P/E 10.65) and strong profitability (ROE 34.94%), though investors face risks from competitive pressures and potential margin compression as the company expands its bundled insurance offerings. The stock offers 8% upside to consensus target with balanced risk-reward profile.
Trailing returns across standard periods
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →